Dr. Ania Jastreboff

The Oprah Podcast

Harpo

Society & Culture

4.6 • 711 Ratings

🗓️ 14 January 2025

⏱️ 57 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In this episode of The Oprah Podcast, Oprah sits down with Dr. Ania Jastreboff, an endocrinologist and associate professor at the Yale School of Medicine, to talk about the new GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound. Dr. Ania, who has been on the forefront of GLP-1 medication research for the past 20 years, will talk through why it is biologically difficult for some people to lose weight, maintain weight loss and why obesity is a disease. She explains how the new GLP-1 medications work, how they can facilitate weight loss, and if they are safe. Dr. Ania answers questions from people around the country who are taking the GLP-medications and have lost a significant amount of weight. We will also share an update from Amy Kane who told her story of losing 160 pounds on weight loss medications last year on Oprah’s ABC Special: Shame, Blame and the Weight Loss Revolution. Also referenced in this episode: "The Let Them Theory: A Life-Changing Tool That Millions of People Can’t Stop Talking About" by Mel Robbins, published by Hay House LLC is available wherever books and audio books are sold. SUPPORT THE SHOW Subscribe: https://www.youtube.com/@Oprah Find Oprah’s Interview with Mel Robbins Here. Follow Amy on Instagram Follow Amy on TikTok Follow Emma on TikTok Follow Emma on Instagram Follow Oprah Winfrey on Social: Instagram Facebook Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	Whether you are listening on the Oprah podcast or watching on YouTube, I appreciate you being with us.
0:06.6	Last year, millions tuned into my special on ABC, shame, blame, and the weight loss revolution.
0:13.4	It's now streaming on Hulu if you want to check it out.
0:16.2	We're continuing the conversation around weight loss medications like Ozympic and Manjaro. People still don't
0:22.7	understand it. Is it the easy way out? It's absolutely the opposite. I'm joined on this podcast by Dr.
0:28.7	Anya Yastrovov, an endocrinologist and associate professor at the Yale School of Medicine. She has been
0:34.9	studying GLP1 medications for more than 20 years. Obesity is not a choice.
0:41.1	It is about biology. We are diving into the latest research on these medications that roughly
0:47.9	15 million Americans are now using. Can you set the record straight on side effects?
0:53.4	Dr. Anya is here to answer a lot of your
0:55.9	common questions. Is this something I could taper off of? You may remember Amy, who I met on the ABC
1:02.8	special. She had lost 160 pounds after starting a prescription of Monjaro. She's zooming in with an
1:09.7	update. Hello, hello. Good to see you again. It's zooming in with an update. Hello, hello.
1:12.0	Good to see you again.
1:13.1	It's so good to see you.
1:14.8	A quick note, my guests on this podcast asked us to show there before and after weight
1:20.4	lost pictures because they believe the photos are a vital part of their life's journey.
1:28.1	It's wonderful to talk to you again.
1:30.1	You know, that new study says that nearly 75% of American adults are overweight or obese.
1:39.1	So what determines obesity versus overweight, just being overweight?
1:43.5	Okay.
1:44.6	So in terms of that first question, right now, there aren't really great definitions.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Harpo, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Harpo and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.